Daniel Pollyea, MD, elaborates on the evolving treatment landscape in myelodysplastic syndromes
2 Views
administrator
07/04/23
Dr. Pollyea, Associate Professor/Clinical Director of Leukemia Services, Division of Hematology, University of Colorado School of Medicine, elaborates on how the treatment of myelodysplastic syndromes is changing as a result of clinical data presented at ASH 2019
-
Category
Show more
Facebook Comments
No comments found